Gunnar Söderdahl

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma

Edward K. Geissler, Andreas A. Schnitzbauer, C. Zülke et al. · Transplantation · 2015 · 409 citations · Full text

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

Peter Bergman, Ola Blennow, Lotta Hansson et al. · EBioMedicine · 2021 · 219 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

Andreas A. Schnitzbauer, Carl Zuelke, Christian Graeb et al. · BMC Cancer · 2010 · 159 citations · Full text

mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

Andreas A. Schnitzbauer, Natalie Filmann, René Adam et al. · Annals of Surgery · 2020 · 133 citations · Full text

Differential expression of platelet‐derived growth factor and transforming growth factor genes in small‐ and non‐small‐cell human lung carcinoma lines

Gunnar Söderdahl, Christer Betsholtz, A. Johanson et al. · International Journal of Cancer · 1988 · 77 citations